(1)
Brusamolino, E.; Gotti, M.; Fiaccadori, V. THE RISK OF THERAPY-RELATED MYELODYSPLASIA ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY. Mediterr J Hematol Infect Dis 2012, 4, e2012022.